
### [NCIT:C4298](http://purl.obolibrary.org/obo/NCIT_C4298)
**Label:** Epithelioid Hemangioma

**Subclasses:** [NCIT:C7393](http://purl.obolibrary.org/obo/NCIT_C7393) (Skin Epithelioid Hemangioma), [NCIT:C5396](http://purl.obolibrary.org/obo/NCIT_C5396) (Bone Epithelioid Hemangioma), [NCIT:C5211](http://purl.obolibrary.org/obo/NCIT_C5211) (Breast Epithelioid Hemangioma), 

**Class expressions from DL-Learner:**

- Thing 51.63%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39896](http://purl.obolibrary.org/obo/NCIT_C39896) (Prostate Ductal Adenocarcinoma, Papillary Pattern))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39895](http://purl.obolibrary.org/obo/NCIT_C39895) (Prostate Ductal Adenocarcinoma, Cribriform Pattern))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C3989](http://purl.obolibrary.org/obo/NCIT_C3989) (Parathyroid Hyperplasia))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39885](http://purl.obolibrary.org/obo/NCIT_C39885) (Acinar Prostate Adenocarcinoma, Lymphoepithelioma-Like Variant))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39880](http://purl.obolibrary.org/obo/NCIT_C39880) (Acinar Prostate Adenocarcinoma, Atrophic Variant))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39875](http://purl.obolibrary.org/obo/NCIT_C39875) (Loss of Chromosome 9q))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39874](http://purl.obolibrary.org/obo/NCIT_C39874) (Urethral Verrucous Carcinoma))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39862](http://purl.obolibrary.org/obo/NCIT_C39862) (Human Papillomavirus-Related Urethral Squamous Cell Carcinoma))) 47.86%
- [NCIT:C37093](http://purl.obolibrary.org/obo/NCIT_C37093) (Epithelioid Endothelial Cell) and (not ([NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma))) 47.86%


